Coloplast, DK0060448595

Coloplast stock heads into the open after a 0.75% gain

Published on 09/15/2026 at 04:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 14, 2026, Coloplast stock on Nasdaq Copenhagen was up 0.75%, ending the session at DKK 419.20. Compared with the OMXC Large Cap index, the shares showed a modest outperformance as Danish large caps moved mixed on the day.

Pop-Art-Comic-Illustration einer lächelnden Pflegekraft mit medizinischen Pflegeprodukten
Coloplast A/S (DK0060448595) als Medizintechnik-Firma inspiriert diese farbenfrohe Pop-Art-Comic-Szene mit einer freundlichen Pflegekraft dargestellt, Illustration mit AI erstellt.

Coloplast stock closed at DKK 419.20 on Nasdaq Copenhagen on September 14, 2026, rising 0.75% from the prior session. The move came on a day when Danish large cap shares traded mixed, leaving Coloplast modestly ahead of the broader OMXC Large Cap index.

September 14, 2026 in numbers

Coloplast A/S (ISIN DK0060448595) ended the September 14, 2026 session on Nasdaq Copenhagen at DKK 419.20, after adding 0.75% during the trading day. Per data from the Copenhagen market overview, Coloplast B A/S was listed among the more actively traded names, with its closing level situated comfortably within the recent range of Danish blue chips, although specific intraday high, low and volume figures were not highlighted in the available exchange summary from Nordnet. The OMXC Large Cap index itself showed a mixed performance across constituents on September 14, 2026, with several major Danish names such as Novo Nordisk, A.P. Møller - Mærsk and Ørsted posting both gains and losses, indicating an uneven risk mood on the Copenhagen exchange according to the same Nordnet market overview.

Today’s drivers to watch

Today, September 15, 2026, Coloplast enters the new session without any newly published company-specific announcements or scheduled events in the immediate earnings or corporate calendar that materially change the backdrop ahead of the open, based on the most recent Danish market information pages such as the Copenhagen overview from Nordnet. Broader market sentiment in Europe and global equity benchmarks, including large-cap indices highlighted in recent international market wraps like the mid-September 2026 review by Zacks, remain important context for Coloplast today, as investors assess risk appetite following notable moves in global technology and healthcare shares over the past sessions.

Disclaimer...

en | DK0060448595 | COLOPLAST | boerse | 70102510 | bgmi